JPRN-UMIN000032515招募中未知
HEMLIBRA Subcutaneous injection General Drug Use Surveillance(in Hemophilia A with Inhibitors). - HEMLIBRA General Drug Use Surveillance(in Hemophilia A).
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •No criteria
研究者
相似试验
招募中
不适用
HEMLIBRA Subcutaneous Injection, General drug use-results survey - Routine prophylaxis to prevent or reduce the frequency of bleeding episodes in patients with acquired hemophilia ARoutine prophylaxis to prevent or reduce the frequency of bleeding episodes in patients with acquired hemophilia AJPRN-UMIN000048156Chugai Pharmaceutical Co. Ltd.150
已完成
不适用
HEMLIBRA Subcutaneous injection Special Drug Use Surveillance (with Hemophilia A without Inhibitors).Hemophilia AJPRN-UMIN000037503Chugai Pharmaceutical Co. Ltd.87
招募中
Unknown
EPKINLY Subcutaneous Injection General use-results surveillance (All case): OBSC3013-39D-ERelapsed or refractory large B-cell lymphoma and relapsed or refractory follicular lymphomaJPRN-jRCT2031230525Genmab K.K. Drug safety and pharmacovigilance250
已完成
不适用
The therapeutic effect of intradermal injection of Measles, Mumps, and Rubella vaccine in treatment of palmoplantar warts in patients unresponsive to treatmentIRCT2016101027636N3Vice chancellor for Research of Mazandaran University of Medical Sciences60
招募中
2 期
effects of rituximab in patients with pemphigus vulgaris with oral lesionsIRCT20240604062002N1Tabriz University of Medical Sciences20